W
William E. Kraus
Researcher at Duke University
Publications - 625
Citations - 40583
William E. Kraus is an academic researcher from Duke University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 93, co-authored 565 publications receiving 33692 citations. Previous affiliations of William E. Kraus include University of Texas Southwestern Medical Center & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Gene-smoking interactions in multiple Rho-GTPase pathway genes in an early-onset coronary artery disease cohort.
Cavin K. Ward-Caviness,Carol Haynes,Colette Blach,Elaine Dowdy,Simon G. Gregory,Svati H. Shah,Benjamin D. Horne,William E. Kraus,Elizabeth R. Hauser,Elizabeth R. Hauser +9 more
TL;DR: A pathway-based analysis of the association results using WebGestalt revealed several enriched pathways including the regulation of the actin cytoskeleton pathway as defined by the Kyoto Encyclopedia of Genes and Genomes.
Journal ArticleDOI
Association Between Insulin Resistance, Plasma Leptin, and Neurocognition in Vascular Cognitive Impairment.
Patrick Smith,Stephanie Mabe,Andrew Sherwood,Michael A. Babyak,P. Murali Doraiswamy,Kathleen A. Welsh-Bohmer,William E. Kraus,James R. Burke,Alan L. Hinderliter,James A. Blumenthal +9 more
TL;DR: In overweight and obese adults with vascular CIND, the association between greater weight and poorer executive function may be mediated by higher leptin resistance.
Journal ArticleDOI
Evaluation of PM 2.5 air pollution sources and cardiovascular health
Erik Slawsky,Cavin K. Ward-Caviness,Lucas M. Neas,Robert B. Devlin,Wayne E. Cascio,Armistead G. Russell,Ran Huang,William E. Kraus,Elizabeth R. Hauser,David Diaz-Sanchez,Anne M. Weaver +10 more
TL;DR: In this article, the authors used mixed effects multivariable logistic regression with a random intercept for county and multiple adjustments to estimate source-specific long-term impacts on the prevalence of coronary artery disease and myocardial infarctions.
Journal ArticleDOI
GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases
TL;DR: GlycA appears to be a promising new composite biomarker of active systemic inflammation including assessing CVD risk in patients with inflammatory diseases.
Journal ArticleDOI
Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease
TL;DR: Overall, 12-weeks of aerobic, resistance, the combination of aerobic and resistance, and novel training modalities, including acceleration and hybrid training, significantly improve liver enzymes and hepatic fat.